Status:
COMPLETED
Immune Dysfunction in Allergic Asthma
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Asthma
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
We are using anti-IgE to investigate the role of pulmonary mast cells in asthma.
Detailed Description
Subjects with mild allergic asthma are examined before, immediately after and 2 months after a course of treatment with anti-IgE. The following are examined: Allergen skin tests, allergen induced asth...
Eligibility Criteria
Inclusion
- Mild asthma, adults -
Exclusion
- children. on inhaled or systemic steroids
- \-
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00189228
Start Date
September 1 2005
End Date
June 1 2008
Last Update
September 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNM HSC
Albuquerque, New Mexico, United States, 87131